What is Imagion Biosystems Limited's current stock price?

Imagion Biosystems Limited (IBX.AX) currently trades at AUD 0.008000. Track real-time price changes and historical performance on AllInvestView.

What sector is Imagion Biosystems Limited in?

Imagion Biosystems Limited operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Imagion Biosystems Limited IBX.AX · Stock Open Imagion Biosystems Limited in new tab

0.008000 AUD

Add to portfolio

EPS

-0.01

P/B

-1.33

Beta

-0.23

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Imagion Biosystems Limited (IBX.AX)

Currency: AUD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Imagion Biosystems Limited Analysis (IBX.AX)

United States Health Care Official Website Stock

Is Imagion Biosystems Limited a good investment? Imagion Biosystems Limited (IBX.AX) is currently trading at 0.008000 AUD.

Earnings Schedule: Imagion Biosystems Limited is expected to release its next earnings report on Feb. 26, 2026.

Investor FAQ

Does Imagion Biosystems Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Imagion Biosystems Limited?

Imagion Biosystems Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 26, 2026. The company currently has a trailing EPS of -0.01.

Company Profile

Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.

Exchange Ticker

PNK (United States) IBXXF

ASX (Australia) IBX.AX

Trades

Dividend History paid per year (AUD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
Nov. 16, 2023	0.03

Imagion Biosystems Limited IBX.AX · Stock Open Imagion Biosystems Limited in new tab

Key Metrics

Growth

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Imagion Biosystems Limited Analysis (IBX.AX)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Imagion Biosystems Limited IBX.AX · Stock Open Imagion Biosystems Limited in new tab

Key Metrics

Growth

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Imagion Biosystems Limited Analysis (IBX.AX)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications